Phastar Sustainability Profile
Phastar, a leading provider of statistical and data science services, is headquartered in Great Britain and operates across Europe and North America. Founded in 2015, the company has quickly established itself in the pharmaceutical and biotechnology sectors, offering innovative solutions in clinical trial data analysis and reporting. Phastar's core services include advanced statistical programming, data management, and regulatory submissions, distinguished by their commitment to quality and precision. The company has achieved significant milestones, including rapid growth and recognition for its expertise in delivering complex data solutions. With a strong market position, Phastar is known for its collaborative approach and deep understanding of regulatory requirements, making it a trusted partner for clients navigating the complexities of clinical development.
DitchCarbon Score
How does Phastar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Phastar's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Phastar's reported carbon emissions
Phastar, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. While there are no specific emissions figures to report, it is important to note that Phastar does not inherit emissions data from any parent organization, such as Amphastar Pharmaceuticals, Inc. This indicates that their climate strategy and emissions reporting are independent and not influenced by external corporate family relationships. As the industry increasingly prioritises sustainability, Phastar may consider developing measurable climate commitments and reduction initiatives to align with global standards and expectations.
How Carbon Intensive is Phastar's Industry?
How Carbon Intensive is Phastar's Location?
Phastar's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Phastar has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
